Genprex to Participate at BIO Europe Spring 2025
AUSTIN, Texas, March 4, 2025 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy... Read more.
Robles BioCeutics Appoints Chief Financial Officer
Dr. Joseph Ellis to Drive Next Phase of Growth for Stem Cell Senolytics Biotechnology Company SAN DIEGO, March 4, 2025 /PRNewswire/ — Robles BioCeutics, a... Read more.
RevSpring Announces SeatMate™, an AI-Powered Virtual Agent Embedded in PersonaPay™ for Intelligent Engagement
SeatMate guides meaningful interactions by infusing every conversationwith patient insights—elevating the patient experience and driving the mostdesired outcomes... Read more.
Vintage Investment Partners Appoints Iren Reznikov as a Partner
TEL AVIV, Israel, March 4, 2025 /PRNewswire/ — Vintage Investment Partners, a global venture capital platform with over $4 billion under management, is pleased... Read more.
Dermata Announces that Last Patient Completes Last Visit in Pivotal XYNGARI™ Phase 3 STAR-1 Clinical Trial for Acne
– STAR-1 topline results expected by the end of March 2025 – – Over 30 million acne patients seek treatment in the U.S. each year – –... Read more.
Exclusive Look Inside Binance Blockchain Week: New Docuseries Reveals All
DUBAI, UAE, March 4, 2025 /PRNewswire/ — Binance, the global blockchain ecosystem behind the largest crypto exchange by trading volume, announced the launch... Read more.
First Legal Acquires New York-Based Inter County Judicial Services (IJS)
Litigation Support Leader Expands Into Nation’s Premier Legal Market NEW YORK, March 4, 2025 /PRNewswire/ — First Legal, the nation’s leading... Read more.
Afinida Marketing Doubles in Size to Facilitate Increasing Client Demand
Marketing team adds new members to bolster full-service capabilities. SAN DIEGO, March 4, 2025 /PRNewswire/ — Trucept Inc. (OTC Pink: TREP), DBA Afinida (“the... Read more.
Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference
SAN DIEGO, March 4, 2025 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative... Read more.
P3 Services Accelerates National Expansion with Multiple Strategic Acquisitions Across the U.S. Over the Last Year
HOCKLEY, Texas, March 4, 2025 /PRNewswire/ — P3 Services (“P3”), a leading provider of comprehensive plumbing and septic solutions, has announced... Read more.